Home | All intervention

[RDF data]
Intervention #100271 (Drug:Octreotide Long Active Release)

Resource URI: http://static.linkedct.org/resource/intervention/100271
linkedct:description Patients will receive the first dose of Sandostatin LAR (30 mg) at chemotherapy initiation, in addition to a minimum of two more identical monthly doses of Sandostatin LAR (with an interval of 28 days between them), until first-line chemotherapy is discontinued or for a maximum of six doses of Sandostatin LAR, whichever occurs first.
is linkedct:intervention of <http://static.linkedct.org/resource/trials/NCT00582426>
linkedct:intervention_id 100271 (xsd:int)
linkedct:intervention_name Octreotide Long Active Release
linkedct:intervention_type Drug
rdfs:label Intervention #100271 (Drug:Octreotide Long Active Release)
rdf:type linkedct:intervention